NUVB – nuvation bio inc. class a (US:NASDAQ)
Stock Stats
News
Nuvation Bio to Present at the Jones Healthcare and Technology Innovation Conference
Nuvation Bio Inc. (NYSE: NUVB) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $5.00 price target on the stock.
Nuvation Bio to Present New Nonclinical Data for Taletrectinib at the American Association for Cancer Research Annual Meeting 2025
Nuvation Bio to Present Matching-adjusted Indirect Comparison Data for Taletrectinib vs. Crizotinib During Mini Oral Presentation at the European Lung Cancer Congress 2025 [Yahoo! Finance]
Nuvation Bio to Present Matching-adjusted Indirect Comparison Data for Taletrectinib vs. Crizotinib During Mini Oral Presentation at the European Lung Cancer Congress 2025
Form 4 Nuvation Bio Inc. For: Apr 01 Filed by: Mashal Robert
Form 8-K Nuvation Bio Inc. For: Mar 21
Form S-3ASR Nuvation Bio Inc.
Form 10-K Nuvation Bio Inc. For: Dec 31
Form 8-K Nuvation Bio Inc. For: Mar 06
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.